127 related articles for article (PubMed ID: 26979305)
1. Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis.
White MG; Nagar S; Aschebrook-Kilfoy B; Jasmine F; Kibriya MG; Ahsan H; Angelos P; Kaplan EL; Grogan RH
Ann Surg Oncol; 2016 Jul; 23(7):2302-9. PubMed ID: 26979305
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype.
Ellis RJ; Wang Y; Stevenson HS; Boufraqech M; Patel D; Nilubol N; Davis S; Edelman DC; Merino MJ; He M; Zhang L; Meltzer PS; Kebebew E
J Clin Endocrinol Metab; 2014 Feb; 99(2):E329-37. PubMed ID: 24423287
[TBL] [Abstract][Full Text] [Related]
3. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
[TBL] [Abstract][Full Text] [Related]
5. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma.
Lee EK; Chung KW; Yang SK; Park MJ; Min HS; Kim SW; Kang HS
Anticancer Res; 2013 Nov; 33(11):4833-9. PubMed ID: 24222120
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
BMC Cancer; 2020 Nov; 20(1):1143. PubMed ID: 33238942
[TBL] [Abstract][Full Text] [Related]
9. Methylation of p16 CpG islands correlated with metastasis and aggressiveness in papillary thyroid carcinoma.
Wang P; Pei R; Lu Z; Rao X; Liu B
J Chin Med Assoc; 2013 Mar; 76(3):135-9. PubMed ID: 23497965
[TBL] [Abstract][Full Text] [Related]
10. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.
Bisarro Dos Reis M; Barros-Filho MC; Marchi FA; Beltrami CM; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
J Clin Endocrinol Metab; 2017 Nov; 102(11):4089-4099. PubMed ID: 28938489
[TBL] [Abstract][Full Text] [Related]
12. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
13. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
[TBL] [Abstract][Full Text] [Related]
14. A methodological study of genome-wide DNA methylation analyses using matched archival formalin-fixed paraffin embedded and fresh frozen breast tumors.
Espinal AC; Wang D; Yan L; Liu S; Tang L; Hu Q; Morrison CD; Ambrosone CB; Higgins MJ; Sucheston-Campbell LE
Oncotarget; 2017 Feb; 8(9):14821-14829. PubMed ID: 28118602
[TBL] [Abstract][Full Text] [Related]
15. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
16. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma.
Zhang S; Wang Y; Chen M; Sun L; Han J; Elena VK; Qiao H
Sci Rep; 2017 Mar; 7():44033. PubMed ID: 28272462
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
Yi JW; Kim SJ; Kim JK; Seong CY; Yu HW; Chai YJ; Choi JY; Lee KE
Ann Surg Oncol; 2017 Nov; 24(12):3754-3762. PubMed ID: 28124274
[TBL] [Abstract][Full Text] [Related]
18. Global DNA methylation profile in medullary thyroid cancer patients.
Ceolin L; Goularte APP; Ferreira CV; Romitti M; Maia AL
Exp Mol Pathol; 2018 Aug; 105(1):110-114. PubMed ID: 29935954
[TBL] [Abstract][Full Text] [Related]
19. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.
Abubaker J; Jehan Z; Bavi P; Sultana M; Al-Harbi S; Ibrahim M; Al-Nuaim A; Ahmed M; Amin T; Al-Fehaily M; Al-Sanea O; Al-Dayel F; Uddin S; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Feb; 93(2):611-8. PubMed ID: 18000091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
